Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues up 29% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech
 
2Q Revenues: $130.4 million (+29%)

2Q Earnings: $20.5 million (+10%)

YTD Revenues: $248.4 million (+28%)

YTD Earnings: $41.5 million (+12%)

Comments: Laboratory Services revenues grew 25% in the quarter to $93.6 million.
China-Based Lab Services revenue was up 27% to $70.3 million. U.S.-Based Lab Services revenue was up 18% to $23.3 million. Manufacturing Services revenue grew 41% to $36.8 million.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters